Investing in Psychedelics, Psilocybin, or Magic Mushrooms
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
China Enters Magic Mushroom Industry – Wuhan, MJMedTech, and M2BIO
On April 05, 2019, Wuhan General Group, Inc. announced that its subsidiary MJ MedTech, Inc. (MJ MedTech) has created a new division dedicated to exploring opportunities in the psychedelic medicine …
$800 Million Valuation for First Psilocybin Company?
Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry. Investments by several early movers illustrate that a psilocybin industry …
Psilacetin and Psilocybin — Two Equivalent Means for Administering Psilocin
The molecule Psilacetin (aka 4-AcO-DMT or O-Acetylpsilocin) is a synthetic psilocybin derivative. Like psilocybin, psilacetin serves as a prodrug of psilocin, which is the primary active molecule responsible for the …
The Future of Magic Mushrooms is Formulations of Tryptamines
Several organizations in the United States and worldwide are seeking to legalize or decriminalize “magic mushrooms” (the organism) and/or psilocybin (the molecule). At a high level, these two approaches represent …
Canopy Growth Corp Partners With NHL Alumni to Develop Cannabis-Based Treatments for Neurological Diseases
The National Hockey League Alumni Association (herein “NHLAA”) recently entered into a partnership with Canopy Growth Company (“CGC” or “Canopy”). The Canopy-NHLAA collaboration will focus on exploring cannabis-based neurological treatments …
What is the value of the “Magic Mushroom” or Psilocybin Market?
All signs point to the rise of psilocybin technology. This raises questions regarding the size of the future psilocybin industry. How much will psilocybin products cost consumers? How much will …
Rolling Stone: The Future of Cannabis is Formulations of Cannabinoids
Madison Margolin recently published an article in Rolling Stone Magazine explaining that the future of cannabis technology will center around formulated products that eliminate the inherent variability of natural cannabis. …
Tim Ferriss and Psychedelics
Best-selling author, entrepreneur, and angel investor Tim Ferriss praises the benefits of psychedelics. Mr. Ferriss financially supports psychedelic research and he methodically uses psychedelics for treating depression and enhancing cognition. …
No Magic Mushroom Monopoly
No Magic Mushroom Monopoly Relax. No one is trying to monopolize magic mushrooms. COMPASS Pathways is not trying to monopolize magic mushrooms. Renewed interest in psychedelic medicine (e.g., psilocybin) is not part …